{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:49:09Z","timestamp":1783784949002,"version":"3.55.0"},"reference-count":56,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018293","name":"Amryt Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pregnancy represents an additional challenge to the complex clinical picture of lipodystrophy disorders, and the management of such conditions with related comorbidities has been underreported. This work aims to outline the risk associated with a pregnancy event for women dealing with acquired partial lipodystrophy and the need for diverse but specialized care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case<\/jats:title>\n                  <jats:p>We report on the successful pregnancy outcome of a 28-year-old woman with an acquired partial form of lipodystrophy related to an allogenic bone marrow transplant that occurred at pediatric age. Although metabolic control was challenging, glucose levels progressively improved during the pregnancy, and triglycerides increased less than expected. The periodic monitoring of leptin levels showed a progressive increase with a peak in the third trimester (41.53\u2005ng\/mL), followed by a fast decline the day after giving birth, with a lower basal level than the prepregnancy period. However, preterm delivery occurred associated with cardiac complications in the mother.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 12 studies were retrieved concerning women aged 14 to 38 years with various lipodystrophy phenotypes. Diabetes and hypertriglyceridemia were the most common comorbidities. Most women had successful pregnancies despite gestational complications (including miscarriages), preterm and emergency deliveries, and newborns undergoing partum or postpartum transient or chronic complications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Lipodystrophy disorders expose both mothers and children to very high risk. Intensive monitoring and care of all potential clinical complications should be planned and carried out by a multidisciplinary team before, during, and after the pregnancy. Leptin secretion during pregnancy should be investigated more deeply in these patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/jendso\/bvae181","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T08:12:35Z","timestamp":1729498355000},"source":"Crossref","is-referenced-by-count":3,"title":["Acquired Partial Lipodystrophy: Clinical Management in a Pregnant Patient"],"prefix":"10.1210","volume":"8","author":[{"given":"Martina","family":"Romanisio","sequence":"first","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Bighetti","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Daffara","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo Luigi Maria","family":"Mollero","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[{"name":"Chemistry and Endocrinology Laboratory, Department of Laboratory Medicine, University Hospital of Pisa , Pisa 56126 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Antoniotti","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]},{"name":"Department of Health Sciences, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Ciamparini","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Aimaretti","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Caputo","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]},{"name":"Department of Health Sciences, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-5335","authenticated-orcid":false,"given":"Flavia","family":"Prodam","sequence":"additional","affiliation":[{"name":"Endocrinology, Department of Translational Medicine, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]},{"name":"Department of Health Sciences, Universit\u00e0 del Piemonte Orientale , Novara 28100 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"1","key":"2025021210521733600_bvae181-B1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"12","key":"2025021210521733600_bvae181-B2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"3","key":"2025021210521733600_bvae181-B3","doi-asserted-by":"crossref","first-page":"luad066","DOI":"10.1210\/jcemcr\/luad066","article-title":"A visual diagnosis: lipodystrophy","volume":"1","author":"Bhat","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"11","key":"2025021210521733600_bvae181-B4","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/jc.2018-02730","article-title":"Comorbidities and survival in patients with lipodystrophy: an international chart review study","volume":"104","author":"Akinci","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025021210521733600_bvae181-B5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ando.2019.10.003","article-title":"Lipodystrophic syndromes: from suspicion to treatment","volume":"18","author":"Sollier","year":"2020","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2025021210521733600_bvae181-B6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13023-023-02714-5","article-title":"The metreleptin effectiveness and safety registry (MEASuRE): concept, design and challenges","volume":"18","author":"Haymond","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2025021210521733600_bvae181-B7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2025021210521733600_bvae181-B8","first-page":"65","article-title":"Endocrine late effects of childhood cancer therapy: a report from the childrens oncology group","volume":"69","author":"Nandagopal","year":"2008","journal-title":"Horm Res"},{"issue":"4","key":"2025021210521733600_bvae181-B9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1182\/blood-2006-05-022335","article-title":"Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study","volume":"109","author":"Baker","year":"2007","journal-title":"Blood"},{"issue":"11","key":"2025021210521733600_bvae181-B10","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1210\/jc.2006-0128","article-title":"Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors","volume":"91","author":"Neville","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025021210521733600_bvae181-B11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/bmt.2010.144","article-title":"High incidence of fatty liver and insulin resistance in longterm adult survivors of childhood SCT","volume":"46","author":"Tomita","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2025021210521733600_bvae181-B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP12115.OR","article-title":"Severe insulin resistance and hypertriglyceridemia after childhood total body irradiation","volume":"19","author":"Mayson","year":"2013","journal-title":"Endocr Pract"},{"issue":"11","key":"2025021210521733600_bvae181-B13","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/pbc.25601","article-title":"Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes","volume":"62","author":"Wei","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2025021210521733600_bvae181-B14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1297\/cpe.22.53","article-title":"Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy","volume":"22","author":"Adachi","year":"2013","journal-title":"Clin Pediatr Endocrinol"},{"issue":"2","key":"2025021210521733600_bvae181-B15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1297\/cpe.26.99","article-title":"Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey","volume":"26","author":"Adachi","year":"2017","journal-title":"Clin Pediatr Endocrinol"},{"issue":"11","key":"2025021210521733600_bvae181-B16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s40618-017-0731-x","article-title":"Acquired partial lipodystrophy after bone marrow transplant during childhood: a novel syndrome to be added to the disease classification list","volume":"40","author":"Ceccarini","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"2025021210521733600_bvae181-B17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"5","key":"2025021210521733600_bvae181-B18","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2337\/dci23-0038","article-title":"Atypical diabetes: what have we learned and what does the future hold?","volume":"47","author":"Stone","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"2025021210521733600_bvae181-B19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diabet.2012.02.012","article-title":"Vascular placental abnormalities and newborn death in a pregnant diabetic woman with familial partial lipodystrophy type 3: a possible role for peroxisome proliferator-activated receptor \u03b3","volume":"38","author":"Castell","year":"2012","journal-title":"Diabetes Metab"},{"issue":"1","key":"2025021210521733600_bvae181-B20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4158\/EP.6.1.34","article-title":"Successful outcome of pregnancy in a patient with generalized lipoatrophic diabetes mellitus","volume":"6","author":"Dolberg","year":"2000","journal-title":"Endocr Pract"},{"issue":"2","key":"2025021210521733600_bvae181-B21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/01443610500051700","article-title":"Familial partial lipodystrophy complicated by pre-eclampsia","volume":"25","author":"Panchal","year":"2005","journal-title":"J Obstet Gynaecol"},{"issue":"3","key":"2025021210521733600_bvae181-B22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/1753495X13516441","article-title":"A woman with familial partial lipodystrophy and the complications of her four pregnancies","volume":"7","author":"Nijjar","year":"2014","journal-title":"Obstet Med"},{"issue":"2 Pt 2","key":"2025021210521733600_bvae181-B23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/AOG.0b013e31822cecf7","article-title":"Pregnancy in a woman with congenital generalized lipodystrophy: leptin's vital role in reproduction","volume":"119","author":"Maguire","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"10","key":"2025021210521733600_bvae181-B24","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1111\/j.1464-5491.2012.03742.x","article-title":"A complicated pregnancy in a patient with lipodystrophic diabetes attributable to a peroxisome proliferator-activated receptor gamma (PPARG) mutation","volume":"29","author":"Madhra","year":"2012","journal-title":"Diabet Med"},{"issue":"1","key":"2025021210521733600_bvae181-B25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13104-015-1065-4","article-title":"Familial partial lipodystrophy, dunnigan variety\u2014challenges for patient care during pregnancy: a case report","volume":"8","author":"Belo","year":"2015","journal-title":"BMC Res Notes"},{"issue":"10","key":"2025021210521733600_bvae181-B26","first-page":"850","article-title":"Successful pregnancy in a woman with lipoatrophic diabetes mellitus. A case report","volume":"45","author":"Morse","year":"2000","journal-title":"J Reprod Med"},{"issue":"3","key":"2025021210521733600_bvae181-B27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/ejendo\/lvad023","article-title":"Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy","volume":"188","author":"Gosseaume","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025021210521733600_bvae181-B28","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2007-2521","article-title":"Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy","volume":"93","author":"Vantyghem","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021210521733600_bvae181-B29","doi-asserted-by":"crossref","first-page":"1359025","DOI":"10.3389\/fendo.2024.1359025","article-title":"Gestational and neonatal outcomes of women with partial dunnigan lipodystrophy","volume":"15","author":"Valerio","year":"2024","journal-title":"Front Endocrinol"},{"issue":"Suppl 1","key":"2025021210521733600_bvae181-B30","doi-asserted-by":"crossref","first-page":"bvad114.736","DOI":"10.1210\/jendso\/bvad114.736","article-title":"THU301 natural history of pregnancy and pregnancy outcomes in subjects with lipodystrophy","volume":"7","author":"Neal","year":"2023","journal-title":"J Endocr Soc"},{"issue":"4","key":"2025021210521733600_bvae181-B31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5603\/EP.2013.0010","article-title":"Dunnigan-type familial partial lipodystrophy associated with the heterozygous R482W mutation in LMNA gene\u2014case study of three women from one family","volume":"64","author":"Nabrdalik","year":"2013","journal-title":"Endokrynol Pol"},{"issue":"12","key":"2025021210521733600_bvae181-B32","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025021210521733600_bvae181-B33","doi-asserted-by":"crossref","first-page":"e2200301","DOI":"10.1002\/adbi.202200301","article-title":"The clinical characteristics and potential molecular mechanism of LMNA mutation-related lipodystrophy","volume":"7","author":"Xiao","year":"2023","journal-title":"Adv Biol (Weinh)"},{"issue":"3","key":"2025021210521733600_bvae181-B34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1530\/EJE-12-0268","article-title":"Phenotypic diversity in patients with lipodystrophy associated with LMNA mutations","volume":"167","author":"Mory","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"2025021210521733600_bvae181-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000316893","article-title":"Human lipodystrophies: genetic and acquired diseases of adipose tissue","volume":"19","author":"Capeau","year":"2010","journal-title":"Endocr Dev"},{"issue":"10","key":"2025021210521733600_bvae181-B36","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.1210\/en.2010-0131","article-title":"PPARgamma in placental angiogenesis","volume":"151","author":"Nadra","year":"2010","journal-title":"Endocrinology"},{"issue":"2-3","key":"2025021210521733600_bvae181-B37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.placenta.2006.04.009","article-title":"PPARs and the placenta","volume":"28","author":"Fournier","year":"2007","journal-title":"Placenta"},{"issue":"8","key":"2025021210521733600_bvae181-B38","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1096\/fj.201900214R","article-title":"Pharmacological activation of peroxisome proliferator-activated receptor \u03b3 (PPAR-\u03b3) protectsagainst hypoxia-associated fetal growth restriction","volume":"33","author":"Lane","year":"2019","journal-title":"FASEB J"},{"issue":"3","key":"2025021210521733600_bvae181-B39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.placenta.2009.12.009","article-title":"Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia","volume":"31","author":"Holdsworth-Carson","year":"2010","journal-title":"Placenta"},{"issue":"8","key":"2025021210521733600_bvae181-B40","doi-asserted-by":"crossref","first-page":"E1468","DOI":"10.1210\/jc.2012-1064","article-title":"Placental expression of peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3): relation to placental and fetal growth","volume":"97","author":"D\u00edaz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025021210521733600_bvae181-B41","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41569-020-0390-z","article-title":"Pregnancy and cardiovascular disease","volume":"17","author":"Ramlakhan","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"2025021210521733600_bvae181-B42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","article-title":"Diagnostic strategies and clinical management of lipodystrophy","volume":"15","author":"Foss-Freitas","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"8","key":"2025021210521733600_bvae181-B43","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3390\/jcm10081559","article-title":"Lipodystrophy as a late effect after stem cell transplantation","volume":"10","author":"Tews","year":"2021","journal-title":"J Clin Med"},{"key":"2025021210521733600_bvae181-B44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000519414","article-title":"Cardiometabolic risk, part 2: indirect cardiotoxicity in cancer survivors\u2014the emerging role of metabolic syndrome","volume":"54","author":"Felicetti","year":"2021","journal-title":"Front Horm Res"},{"issue":"3","key":"2025021210521733600_bvae181-B45","first-page":"184","article-title":"Pituitary disease and pregnancy","volume":"68","author":"Valassi","year":"2021","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"2","key":"2025021210521733600_bvae181-B46","doi-asserted-by":"crossref","first-page":"bqaa204","DOI":"10.1210\/endocr\/bqaa204","article-title":"The importance of leptin to reproduction","volume":"162","author":"Childs","year":"2021","journal-title":"Endocrinology"},{"key":"2025021210521733600_bvae181-B47","doi-asserted-by":"crossref","first-page":"116129","DOI":"10.1016\/j.bcp.2024.116129","article-title":"Novel mechanisms involved in leptin sensitization in obesity","volume":"223","author":"Pena-Leon","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2025021210521733600_bvae181-B48","doi-asserted-by":"crossref","first-page":"BSR20231916","DOI":"10.1042\/BSR20231916","article-title":"Metabolic hormones are integral regulators of female reproductive health and function","volume":"44","author":"Athar","year":"2024","journal-title":"Biosci Rep"},{"key":"2025021210521733600_bvae181-B49","doi-asserted-by":"crossref","first-page":"1386309","DOI":"10.3389\/fendo.2024.1386309","article-title":"The effects of leptin on human cytotrophoblast invasion are gestational age and dose-dependent","volume":"15","author":"Rumer","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025021210521733600_bvae181-B50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.placenta.2023.09.005","article-title":"Role of leptin in the pathophysiology of preeclampsia","volume":"142","author":"Zeeng","year":"2023","journal-title":"Placenta"},{"key":"2025021210521733600_bvae181-B51","doi-asserted-by":"crossref","first-page":"1172831","DOI":"10.3389\/fendo.2023.1172831","article-title":"Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin","volume":"14","author":"Guadix","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025021210521733600_bvae181-B52","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59249\/JTIV4138","article-title":"Natural physiological changes during pregnancy","volume":"97","author":"Chandra","year":"2024","journal-title":"Yale J Biol Med"},{"issue":"2","key":"2025021210521733600_bvae181-B53","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1530\/JOE-21-0332","article-title":"Programming of cardiometabolic health: the role of maternal and fetal hyperinsulinaemia","volume":"253","author":"Hufnagel","year":"2022","journal-title":"J Endocrinol"},{"issue":"5","key":"2025021210521733600_bvae181-B54","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/0002-9378(87)90142-6","article-title":"Progressive partial lipodystrophy and third-trimester intrauterine fetal death","volume":"156","author":"Fitch","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"2025021210521733600_bvae181-B55","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0002-9378(83)90051-0","article-title":"Progressive partial lipodystrophy in association with intrauterine death and growth retardation","volume":"147","author":"Haxton","year":"1983","journal-title":"Am J Obstet Gynecol"},{"issue":"5 Pt 2","key":"2025021210521733600_bvae181-B56","first-page":"978","article-title":"Successful pregnancy outcome in association with lipoatrophic diabetes mellitus","volume":"76","author":"Catalano","year":"1990","journal-title":"Obstet Gynecol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvae181\/59923362\/bvae181.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/12\/bvae181\/60776326\/bvae181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/8\/12\/bvae181\/60776326\/bvae181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:52:45Z","timestamp":1739357565000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvae181\/7828729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,10,29]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvae181","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,21]]},"article-number":"bvae181"}}